TOFZA XR (Tofacitinib (11mg))
-15%

TOFZA XR (Tofacitinib (11mg))

Original price was: ₹609.40.Current price is: ₹520.00.

Placeholder

Original price was: ₹609.40.Current price is: ₹520.00.

Add to cart
Buy Now
Category: Tag:

Tofza 11mg Extended Release Tablet is indicated for managing moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. This medication works by alleviating pain, tenderness, and joint swelling through its anti-inflammatory properties, and it also helps to slow down potential damage to bones and joints. The medication may be prescribed alone or in conjunction with other treatments. It can be ingested with or without food, but it is advisable to take it at the same time each day for consistency. The prescribed dosage will depend on your specific medical condition and any other medications you may be using, so it is crucial to follow your doctor’s instructions closely. Abruptly discontinuing this medication without medical advice may lead to a deterioration of your condition. Routine blood tests may be required before initiating treatment. It is essential not to start this medication if you currently have any infections. Inform your healthcare provider if you have a history of tuberculosis, shingles, liver disease, kidney disease, hepatitis B or C, or if you have had blood clots in your extremities or lungs. This medication may increase your susceptibility to infections or exacerbate existing ones, so avoid close contact with individuals who have contagious illnesses such as chickenpox or flu. Tofza 11mg Extended Release Tablet is not recommended for individuals under 18 years of age and should only be used during pregnancy or breastfeeding if your healthcare provider determines that the advantages outweigh the risks. Regular check-ups may be necessary during the course of treatment.

Reviews

There are no reviews yet.

Be the first to review “TOFZA XR (Tofacitinib (11mg))”

Your email address will not be published. Required fields are marked *

Top